KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Idexx Laboratories (IDXX) Total Non-Current Liabilities (2016 - 2025)

Historic Total Non-Current Liabilities for Idexx Laboratories (IDXX) over the last 17 years, with Q3 2025 value amounting to $573.7 million.

  • Idexx Laboratories' Total Non-Current Liabilities fell 2070.15% to $573.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $573.7 million, marking a year-over-year decrease of 2070.15%. This contributed to the annual value of $630.2 million for FY2024, which is 2350.36% down from last year.
  • Latest data reveals that Idexx Laboratories reported Total Non-Current Liabilities of $573.7 million as of Q3 2025, which was down 2070.15% from $648.1 million recorded in Q2 2025.
  • Idexx Laboratories' Total Non-Current Liabilities' 5-year high stood at $1.0 billion during Q2 2021, with a 5-year trough of $573.7 million in Q3 2025.
  • Moreover, its 5-year median value for Total Non-Current Liabilities was $893.1 million (2023), whereas its average is $843.4 million.
  • As far as peak fluctuations go, Idexx Laboratories' Total Non-Current Liabilities soared by 765.48% in 2021, and later tumbled by 2395.1% in 2025.
  • Over the past 5 years, Idexx Laboratories' Total Non-Current Liabilities (Quarter) stood at $983.6 million in 2021, then fell by 8.28% to $902.2 million in 2022, then decreased by 8.69% to $823.8 million in 2023, then fell by 23.5% to $630.2 million in 2024, then dropped by 8.97% to $573.7 million in 2025.
  • Its last three reported values are $573.7 million in Q3 2025, $648.1 million for Q2 2025, and $629.5 million during Q1 2025.